Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DaVita HealthCare Partner (NY: DVA )

161.75 -1.41 (-0.86%)
Streaming Delayed Price Updated: 12:40 PM EDT, Sep 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about DaVita HealthCare Partner

< Previous 1 2 3 4 5 6 7 Next >
AdaptHealth Stock Earns RS Rating Upgrade
AdaptHealth stock saw a welcome improvement to its Relative Strength (RS) Rating on Tuesday, rising from 70 to 81. 
Via Investor's Business Daily
3 Red Hot Stocks Flashing Buy Signals: DaVita, Intuitive Surgical, SharkNinja
Stocks making new highs tend to make even higher highs, particularly when analysts' positive earnings estimate revisions come rolling in. That’s been precisely the case for Intuitive Surgical,... 
Via Talk Markets
Bull Of The Day: Davita - Friday, September 6
Known to be the most volatile month for stocks, September is when many investors rebalance their portfolios to include less risky assets such as equities that provide exposure to essential healthcare... 
Via Talk Markets
Top Medical Stocks To Hedge Against The September Effect
While the Fed will likely cut interest rates in the coming weeks, September has historically been the most challenging month for stocks. Here are three top medical stocks to hedge against the September... 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Nvidia is Down 21%. Here Are 3 Better Stocks to Buy for the Rest of 2024
The AI chipmaker has enjoyed a tremendous run-up, but its sky-high valuation means there are better stocks to buy than Nvidia. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Key Takeaways From DaVita Analyst Ratings
Via Benzinga
6 Analysts Assess DaVita: What You Need To Know
Via Benzinga
DaVita (DVA) Q2 2024 Earnings Call Transcript
DVA earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
DVA Stock Earnings: DaVita Beats EPS, Beats Revenue for Q2 2024
DVA stock results show that DaVita beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Financial Crime Weekly: DaVita Agrees To Pay $34.5M For Kickbacks, Hospice Provider Doles Out $19.4M For False Claims
DaVita Inc., a kidney dialysis provider, will pay $34.5 million for allegedly paying kickbacks to competitors and doctors for patient referrals. 
Via Benzinga
2 Warren Buffett Stocks to Buy Hand Over Fist and 1 to Avoid
As the late Meatloaf once sang, "Two out of three ain't bad." 
Via The Motley Fool
Buffett Buys on a Budget: The 3 Cheapest Stocks Held by Berkshire Hathaway
You can't go wrong by following in the Oracle's footsteps and buying these cheap Buffett stocks before the market catches on. 
Via InvestorPlace
These Warren Buffett Stocks Are Trouncing the S&P 500 so Far This Year. Are They Still Buys?
Buffett no doubt likes what he's seeing with these high-flying stocks. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers
Investors urge Fresenius SE to clarify its strategic plans for Fresenius Medical Care after recent deconsolidation. Despite holding a 32% stake, challenges like high dialysis patient mortality and... 
Via Benzinga
Tandem Diabetes Catapults Above A Profit-Taking Zone, But DaVita Reverses, Nearly Triggering A Sell Signal
Tandem Diabetes stock surged above a profit-taking zone on Friday, but DaVita reversed course and tumbled at the open. 
Via Investor's Business Daily
The Big Split: 3 Stock Spinoffs Are Coming. Should You Buy?
Stock spinoffs can unlock shareholder value but management sometimes uses them to get rid of unwanted, slow-growing businesses. 
Via InvestorPlace
DaVita (DVA) Q1 2024 Earnings Call Transcript
DVA earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
DVA Stock Earnings: DaVita Beats EPS, Beats Revenue for Q1 2024
DVA stock results show that DaVita beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
3 Healthcare Stocks With the Potential to Triple Your Investment by 2026
Learn how these three healthcare stocks offer sharp opportunities in pharmaceuticals, healthcare services, and biotechnology. 
Via InvestorPlace
Warren Buffett's 3 Best-Performing Stocks So Far in 2024: Are They Buys Now?
These high-flying Buffett stocks could be attractive to different kinds of investors. 
Via The Motley Fool
Ford, Nvidia Among Top S&P 500 Stocks Monday; Tesla Extends Losses
Ford, United Airlines and megacap AI stock Nvidia were big-cap winners. 
Via Investor's Business Daily
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities
How The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher
ResMed stock reversed higher Thursday after an analyst suggested weight-loss drugs could drive CPAP use. 
Via Investor's Business Daily
The Best Warren Buffett Stocks to Buy With $300 Right Now
Even with $300, many Buffett investments are within reach of the average investor. 
Via The Motley Fool
3 Soaring, Highly-Ranked Value Stocks To Buy In April
The stock market bounced back on Wednesday and looked strong through morning trading Thursday until sellers showed up. 
Via Talk Markets
3 High-Dividend ETFs That Could Be Smart Investments Right Now
These are three great ways to get income in your portfolio without the hard work of choosing stocks and bonds on your own. 
Via The Motley Fool
Topics Bonds ETFs
Exposures Debt Markets
Warren Buffett's Berkshire Hathaway Owns Over 25% of These 4 Companies (Hint: Apple Isn't One of Them)
Berkshire even lists one of these companies as a subsidiary. 
Via The Motley Fool
3 No-Brainer Warren Buffett Stocks to Buy Right Now
Strong brands and market presence make these three companies attractive investments. 
Via The Motley Fool
Why Are Dialysis Provider Stocks Trading Higher On Tuesday?
Novo Nordisk's FLOW trial reveals a 24% reduction in kidney disease progression, cardiovascular events, and death with semaglutide 1.0 mg compared to placebo. Impact on dialysis stocks 
Via Benzinga
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance. 
Via Benzinga
NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were lower, with the Dow Jones index falling more than 200 points on Tuesday. 
Via Benzinga
Topics Stocks
Exposures US Equities
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.